Leukemia
Allo-BMT reduced relapse risk of leukemia but did not improve survival
Published in Blood Weekly, February 16th, 2006
"Between 1988 and 2002, 758 children with AML were treated on Medical Research Council (MRC) AML 10 and AML 12. MRC AML 10 tested the role of bone marrow transplantation following four blocks of intensive chemotherapy and found that while both allo-BMT and autologous bone marrow transplant (A-BMT) significantly reduced the relapse risk (RR), this did not translate into a significant improvement in overall survival (OS)," scientists writing in the journal Leukemia reported.
"A risk group stratification based...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2006-02-16)
More Articles from Blood Weekly
- Biomedical Engineering
Mild hypothermia preserves bioartificial liver loaded with freshly isolated liver cells - Blood Banking
Germ-free closed system developed for clinical banking of umbilical cord blood - Blood Transfusion
RhD typing for blood transfusion is not needed in southeast Asian populations - Cryopreservation
Trehalose improves cryopreservation of human embryonic stem cells - Tissue Engineering
Chondrocyte-seeded constructs better than unseeded carrier material for knee defect repair - Adult Stem Cells
Powerful technique for multiplying adult stem cells may aid therapies - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
